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Analysis of gamma-H2AX foci in blood lymphocytes is a
promising approach for rapid dose estimation to support
patient triage after a radiation accident but has one major
drawback: the rapid decline of foci levels post-exposure cause
major uncertainties in situations where the exact timing
between exposure and blood sampling is unknown. To
address this issue, radiation-induced apoptosis (RIA) in
lymphocytes was investigated using fluorogenic inhibitors of
caspases (FLICA) as an independent biomarker for radiation
exposure, which may complement the gamma-H2AX assay.
Ex vivo X-irradiated peripheral blood lymphocytes from 17
volunteers showed dose- and time-dependent increases in
radiation-induced apoptosis over the first 3 days after
exposure, albeit with considerable interindividual variation.
Comparison with gamma-H2AX and 53BP1 foci counts
suggested an inverse correlation between numbers of residual
foci and radiation-induced apoptosis in lymphocytes at 24 h
postirradiation (P ¼ 0.007). In T-helper (CD4), T-cytotoxic
(CD8) and B-cells (CD19), some significant differences in
radiation induced DSBs or apoptosis were observed, however
no correlation between foci and apoptosis in lymphocyte
subsets was observed at 24 h postirradiation. While gamma-
H2AX and 53BP1 foci were rapidly induced and then
repaired after exposure, radiation-induced apoptosis did not
become apparent until 24 h after exposure. Data from six
volunteers with different ex vivo doses and post-exposure
times were used to test the capability of the combined assay.
Results show that simultaneous analysis of gamma-H2AX
and radiation-induced apoptosis may provide a rapid and
more accurate triage tool in situations where the delay
between exposure and blood sampling is unknown compared
to gamma-H2AX alone. This combined approach may
improve the accuracy of dose estimations in cases where
blood sampling is performed days after the radiation
exposure.  2013 by Radiation Research Society
INTRODUCTION
In a radiation emergency, many potentially exposed
individuals may not be triaged until 24 h post exposure at
the earliest. It is clear that biomarkers whose radiation
signature remain elevated or are induced 24 h post exposure
are needed to aid triage. As the peripheral blood lymphocyte
is the cell type of choice for biological dosimetry (1–4),
detection of proteins involved in senescence or cell cycle
arrest do not make good candidates for analysis due to the
noncycling nature of lymphocytes. Lymphocytes however
are highly radiosensitive (despite being G0 cells) and readily
undergo cell death by apoptosis after exposure to ionizing
radiation (5, 6). This makes detecting radiation-induced
apoptosis (RIA) in lymphocytes a good candidate assay for
biological dosimetry (7).
Apoptosis is the process of programmed cell death,
inducible by both external and internal signaling pathways
or a combination of both (8). After exposure to ionizing
radiation, induced mutations (9), misrepair (6) and/or
unrepaired damage to the DNA [especially unrepaired
double-strand breaks (DSBs)] (10) can severely disrupt cell
homeostasis, prompting proapoptotic signaling resulting in
DNA fragmentation (11), cell shrinkage (12) and ultimately
phagocytosis (13) of what remains. Apoptosis destroys the
cell from within in a controlled manner to minimize
disruption to the surrounding tissue (14). Ionizing radiations
proficiency at cell killing are highlighted by there extensive
use in the treatment of cancer; however this proficiency and
its mutagenic potential also pose a serious health risk to the
general public.
The major players at the end of the apoptosis pathways
are the caspases (15, 16). These cysteine proteases can be
split into roughly two groups, initiator and effectors.
Initiator caspases (8, 9 and 10) are a part of the signaling
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cascade which communicates to the effector caspases (3, 6
and 7) (17). Effector caspases, especially caspase 3 are
responsible for cleaving a large number of targets, which
results in controlled cellular break down (i.e., structural
proteins, DNase zymogens and DNA repair proteins) (18,
19).
To help validate caspase induction as a marker of ionizing
radiation established radiation biomarkers, gamma-H2AX
and 53BP1 (20), have been used to correlate double-strand
break induction and repair with radiation-induced apoptosis
in lymphocytes from healthy donors. The use of the gamma-
H2AX and 53BP1 foci assay is an emerging tool in the field
of biological dosimetry. However, unlike established
biological dosimetry assays such as the dicentric assay
(21), dose estimations based on foci counts are sensitive to
time after exposure to a greater degree than the dicentric
assay (hours vs. months) resulting in rapidly diminishing
sensitivity 24 h after exposure. To offset this inherent
weakness, combining the foci assay with a biomarker whose
peak signal is not reached until many hours or days after
initial exposure would allow for greater sensitivity after 24 h
and better define (and potentially reduce) any uncertainties
in dose estimations. Furthermore, certain lymphocyte
subsets, specifically B-cells, tend to display greater levels
of radiation-induced apoptosis than T-cells (22) and it has
been suggested radiation induced DSBs are heterogeneous
between subsets (23). If so then it may be more
advantageous, to analyze the most radiosensitive subset
rather than the entire lymphocyte population when trying to
detect low doses of radiation.
METHODS
Blood Collection, Lymphocyte Isolation and Irradiation
After obtaining ethical approvals from the Berkshire Research
Ethics Committee (ref. no. 09/H0505/87) and Queen’s University
Belfast school ethics board (ref. no. 12.13v2) and informed consent
from donors, peripheral blood from healthy donors (no previous
medical radiation exposures, aged 24–65) was collected into EDTA
vacutainer tubes. Blood was mixed with an equal volume of PBS and
lymphocytes were isolated using Histopaque-1077 solution (Sigma-
Aldrich) and resuspended in minimum essential medium (supple-
mented with 10% fetal calf serum, 1% L-glutamine and 1% penicillin/
streptomycin) at 378C. Cells were irradiated with different doses of
copper- and aluminum-filtered 250 kVp X rays at 1.7 Gy/min, with
controls sham irradiated. Cells were incubated at 378C, 5% CO2 in a
humidified atmosphere for up to 3 days. Independent samples of
lymphocytes were used for gamma-H2AX and 53BP1 foci assays,
53BP1 and CD marker assays and radiation-induced apoptosis caspase
assays with each assay having their own separate controls.
Fixation, Staining and Scoring of Gamma-H2AX and 53BP1 Foci
Cells were spotted onto glass Superfrost Plus slides (VWR
International) at a concentration of ;1 3 106 cells/ml, fixed using
2% formaldehyde in PBS for 10 min, washed in PBS, permeabilized
using 0.5% (v/v) Triton-X in PBS for 10 min then washed in PBS.
Blocking was achieved using 1% (w/v) bovine serum albumin (BSA)
in PBS for 30 min. Cells were then incubated with a combination of
1:500 mouse monoclonal anti-gamma-H2AX antibody (Abcam) and
1:400 rabbit polyclonal anti-53BP1 antibody (Bethyl Laboratories) in
1% BSA in PBS for 1 h at room temperature. Cells were then washed
in 1% BSA in PBS, incubated in 1:200 anti-mouse AlexaFluor 488
conjugated antibody (Invitrogen), 1:200 anti-rabbit tetramethylroda-
mineisoiocyanate (TRITC) conjugated antibody (Jackson Immuno-
Research) and 200 ng/ml 40,6-diamidino-2-phenylindole (DAPI) in
1% BSA and PBS for 1 h at room temperature, washed in PBS, dried,
mounted with a cover slip using Vectashieldt (Vector Laboratories)
and sealed using nail polish. Gamma-H2AX and 53BP1 foci were
scored by eye with a Nikon Eclipse TE200 epifluorescence
microscope using a 1003 objective with 1.3NA. Fifty cells were
scored for each data point.
Fixation, Staining and Scoring of 53BP1 Foci in Lymphocyte Subsets
The above methods were used for 53BP1 foci analysis with the
exception of the anti-gamma-H2AX antibody being replaced with
1:200 mouse monoclonal anti-CD4, CD8 or CD19 antibody (Abcam).
FIG. 1. Panel A: Dot plot showing forward scatter vs. side scatter of
sham-irradiated (top) and 4 Gy irradiated lymphocytes 24 h
postirradiation (bottom). Panel B: Shows caspase intensity levels in
sham-irradiated or 4 Gy irradiated apoptotic or nonapoptotic
lymphocytes.
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Fixation, Staining and Measurements of Caspase Intensity for
Radiation-Induced Apoptosis
Caspase activation was detected using the FLICA Poly Caspase kit
(Immunochemistry Technologies) as per the manufacturer’s instruc-
tions and briefly repeated here. Isolated peripheral blood lymphocytes
were incubated with 1:150 FLICA for 1 h prior to fixation at a
concentration of 53 105 cells per ml. Cells were then fixed using 2%
formaldehyde in PBS for 10 min, washed in PBS, permeabilized using
0.5% (v/v) Triton-X in PBS for 10 min then washed in PBS. Blocking
was achieved using 1% (w/v) bovine serum albumin (BSA) in PBS for
30 min. Cells were then incubated with 1:200 mouse monoclonal anti-
CD4, CD8, CD19 antibody (Abcam) in 1% BSA and PBS for 1 h at
room temperature or no antibody. Cells were then washed in 1% BSA
in PBS, incubated in 1:200 anti-mouse AlexaFluor 660 conjugated
antibody (Invitrogen), or no secondary antibody if no primary was
applied. Samples stained only with FLICA were then stained with
propidium iodide. Nonapoptotic lymphocytes were selected based on
previously known values for their forward scatter and side scatter, a
constant DNA signal (propidium iodide intensity) and being caspase
negative (Fig. 1), with a minimum of 5,000 cells measured for each
experiment. Apoptotic cells were identified as having a smaller
forward scatter (apoptotic cells shrink), greater side scatter (increasing
complexity of cellular content due to organelle breakdown) and being
caspase positive. Cells labeled with FLICA and CD antibodies were
additionally selected based on the intensity of the CD marker.
RESULTS
In ex vivo irradiated lymphocytes, there were three factors
governing radiation-induced apoptosis from X-ray expo-
sure; the dose received; culture time postirradiation; and
interindividual variation (Fig. 2A). Increasing dose and
subsequent culture time increased radiation-induced apo-
ptosis levels, with radiation-induced apoptosis following a
one-phase exponential function with respect to dose
between 24–72 h postirradiation (Fig. 2B). From Fig. 2B,
it is clear that 0.5 Gy was far more efficient per unit dose at
inducing radiation-induced apoptosis than 4 Gy and both of
these more efficient than 8 Gy. At 24 h, a strong correlation
was observed where individuals whose lymphocytes had the
lowest radiation-induced apoptosis at 0.5 Gy also had the
lowest radiation-induced apoptosis at 4 and 8 Gy (Fig. 2C).
At 48 and 72 h this was less obvious, with either no or
borderline correlation observed.
53BP1 foci counts in T-helper, T-cytotoxic or B-cells
(CD4, CD8 and CD19, respectively) lymphocytes from 14
healthy donors revealed a significant correlation in foci
numbers between T-helper/T-cytotoxic and T-helper/B-cells
at 0.5 h after 0.5 Gy exposure (Fig. 3A), with those with the
lowest foci numbers in T-helper lymphocytes also possessing
lower foci numbers in T-cytotoxic and B-cells, this however
was not seen at 24 h after 0.5 Gy exposure (Fig. 3B). No
significant variation in foci counts for the lymphocytes
subsets were observed at 0.5 h after 0.5 Gy exposure,
however at 24 h after 4 Gy exposure residual 53BP1 foci
numbers were significantly lower in B-cells compared to T-
helper and T-cytotoxic (Fig. 3C). The general trend for
radiation-induced apoptosis in lymphocyte subsets was T-
helper , T-cytotoxic , B-cells, although T-cytotoxic , B-
cells was reversed at 48 h after 4 Gy exposure (Fig. 3D), with
radiation-induced apoptosis in T-cytotoxic and B-cells
significantly elevated against T-helper lymphocytes at 48 h
after 4 Gy exposure. No correlation between foci and
percentage of radiation-induced apoptosis was observed in
any lymphocyte subset 24 h after 4 Gy exposure.
By utilizing a combination of foci scoring and apoptosis
detection in lymphocytes, different irradiation time points
FIG. 2. Panel A: Radiation-induced apoptosis (RIA) in ex vivo
irradiated lymphocytes expressed as a percentage, apoptosis is shown
for 24, 48 and 72 h after exposure. Panel B: One phase exponential
association fits to the data sets at 24, 48 and 72 h, shows good
agreement with the actual data points. Error bars represent the standard
error between the 17 donors (0, 0.5 4 and 8 Gy) or 3 donors (1, 2 and 6
Gy). Panel C: Spearman rank order correlation P values (with
significant values highlighted in bold, P , 0.05) indicate some degree
of correlation in radiation-induced apoptosis in these donors.
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can be easily distinguished by the lack of apoptosis
induction soon after exposure. For dose and time points
that produce similar foci counts (0.5 Gy 0.5 h/4 Gy 24 h),
markedly different levels of radiation-induced apoptosis are
observed within lymphocytes (Fig. 4A). Comparison of
gamma-H2AX and 53BP1 foci counts against radiation-
induced apoptosis in the lymphocytes of 14 healthy donors
highlighted an inverse correlation of increased foci numbers
with lower levels of radiation-induced apoptosis 24 post
exposure (Fig. 4B).
DISCUSSION
Our findings show that radiation-induced apoptosis in ex
vivo X-irradiated lymphocytes is most efficient at lower
doses, with higher doses not inducing the same level of
apoptosis per unit dose. Caspase saturation starts to appear
at ,10 Gy reinforcing the notion of lymphocyte acute
radiosensitivity compared to several other tissues, which
display latent late-responding toxicity (24, 25). In terms of
correlating radiation-induced apoptosis within donors, at
24 h there appeared to be a strong correlation between dose
and radiation-induced apoptosis in individuals. It has been
observed in clinical radiotherapy samples that patients
with the greatest levels of residual gamma-H2AX (26) and
lower radiation-induced apoptosis (27) tended to suffer
from more severe late normal tissue effects. However this
was the only time point where individuals with the greatest
radiation-induced apoptosis for 0.5 Gy also showed the
greatest levels of radiation-induced apoptosis for 4 and 8
FIG. 3. 53BP1 foci numbers in lymphocyte subsets in ex vivo irradiated lymphocytes. Background corrected foci counts in 12 healthy donors
are shown for 0.5 h after 0.5 Gy exposure (panel A) and 24 h after 4 Gy exposure (panel B). Panels C and D: Correlation analysis between foci
numbers in individual donors subsets was performed using Spearman rank order analysis with significant correlations (P, 0.05) indicated with *.
Means foci counts (panel C) and means percentage (%) cells apoptotic (panel D) between subsets were compared using independent student’s t
test with significant differences (P , 0.05) indicated with *.
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Gy, with the lack of a strong correlation at 48 and 72 h
coupled with variable spontaneous (28) and radiation-
induced apoptosis makes drawing conclusions difficult.
When comparing our own radiation-induced apoptosis to
those previously reported it becomes clear that a
significant level of assay-to-assay variation is observed.
Forty-eight hours after a 3 Gy irradiation, Belloni et al.
reported a lymphocyte viability of 70% using trypan blue
occlusion and 50% using a marker of mitochondria
polarization (6). Schmitz et al. observed stark differences
in lymphocyte subset (CD4, CD8 and CD19) radiation-
induced apoptosis using an annexin V reporter (29).
Variations in the amount of apoptosis for each assay could
be due to variability and the stage at which they detect a
cell of being apoptotic. For example increases in p53
levels would be seen in the early stages of apoptosis,
whereas the loss of membrane integrity is considered a late
event. How cells are cultured once extracted from the
donor will also have implications on spontaneous apopto-
sis in lymphocytes (whether culture alters lymphocyte
radiosensitivity is less well understood).
Radiation-induced apoptosis in lymphocyte subsets
displayed a general trend, CD4 , CD8 , CD19 (29), with
the greatest distinction (and only significant one) observed
after 4 Gy. While CD19 positive cells show greatly
increased spontaneous apoptosis and with spontaneous
apoptosis levels practically zero in vivo (unpublished data),
it cannot be dismissed that culturing the lymphocytes in an
ex vivo environment may alter their radiation response. The
lack of correlation between the radiosensitivity of lympho-
cyte subsets within individual patients at either 24 or 48 h
post exposure highlights the variability in intra-donor
radiation-induced apoptosis. It has been shown (30) that
ex vivo irradiated lymphocytes failed to predict acute
toxicity in radiotherapy patients, only late toxicity was
predicted. Cultured lymphocytes in media will not be
exposed to the same external signaling pathways that cells
in an irradiated individual would be. Acute phase proteins
involved in the radiation inflammatory response such as C-
reactive protein and serum amyloid A (31) are secreted from
the liver in response to interleukin signaling after exposure
to ionizing radiation. Further work is needed to compare
radiation-induced apoptosis in vivo to the ex vivo radiation-
induced apoptosis observed within this work to help better
understand the rate of induction and turnover of apoptotic
lymphocytes in vivo.
The lack of correlation between 53BP1 foci and radiation-
induced apoptosis in lymphocyte subsets (but not the total
lymphocyte population) suggests that DSBs do not correlate
with radiation-induced apoptosis in the subsets of healthy
donors selected here. This suggests that while 53BP1 foci
formation (32) and radiation-induced apoptosis (33) in-
crease with ionizing radiation dose, it is known DSBs
induce apoptosis through the activation of p53 through
ATM phosphorylation (34, 35). Therefore, maybe radiation-
induced apoptosis at least partially independent of DSB
formation. However, the lack of correlation between 53BP1
foci and apoptosis, could also be the result of too few
radioresistant or sensitive donors in the general population
to be adequately detected in our small sample size.
By utilizing a combination of foci scoring and apoptosis
detection in lymphocytes, different irradiation time points
can be easily distinguished by the lack of apoptosis
induction soon after exposure. For dose and time points
that produce similar foci counts (0.5 Gy 0.5 h/4 Gy 24 h),
knowledge of when the exposure took place is needed to
help differentiate the dose and reduce the degree of
uncertainty that would be present in any dose estimate.
However the lack of apoptotic lymphocytes in one and not
the other would points towards a more distant exposure time
FIG. 4. Foci per cell vs. percentage radiation-induced apoptosis
(%RIA) in ex vivo irradiated lymphocytes. Panel A: Six healthy
donors, 1 h after 0.5 Gy exposure (*) 4 h after 4 Gy exposure (&); 24
h after 0.5 Gy exposure (n); and 24 h after 4 Gy exposure (^). Data
is corrected for spontaneous foci and apoptosis at all time points
investigated. Panel B: Linear correlation between foci and radiation-
induced apoptosis at 24 h post exposure to 4 Gy in 14 healthy donors
(including the 6 donors from Fig. 3A).
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in the sample containing apoptotic cells. Samples containing
cells with low foci counts but high levels of apoptosis
would again suggest a large exposure has taken place
perhaps days ago.
A potential advantage of measuring the number of
circulating apoptotic lymphocytes as opposed to total
lymphocyte counts or other serum markers is the greater
sensitivity and reduced uncertainty in any dose estimations.
In past radiation emergency scenarios, total lymphocyte
counts have provided dosimetric information on radiation
casualties (36). However due to the large intervariation and
intravariation between individuals dose estimates carry with
them large uncertainties with only high total-body doses
generally detectable (37). Rather than measure total cells,
determining the number of apoptotic (or even necrotic)
lymphocytes may allow dose estimates down to low doses
(,500 mGy) if the number of background circulating
apoptotic lymphocytes is low.
CONCLUSION
T-helper, T-cytotoxic and B-cells do not show consistent
and strongly significantly different radiation responses from
each other, for biodosimetry this makes analyzing individ-
ual subsets unnecessary. However, using caspase activation
and inhibition as a biomarker of radiation exposure has
shown promising results. When coupled with foci scoring a
more accurate estimation of time and extent of exposure can
be made. The sensitivity of the caspase assay highlights the
usefulness of quantifying the number of radiation induced
apoptotic lymphocytes, in conjunction with gamma-H2AX
foci, for biological dosimetry. If confirmed in vivo, this may
potentially allow for dose estimations of greater accuracy
with fewer uncertainties when compared to those estimates
made by each assay alone or currently used hematological
measurements, such as total lymphocyte counts.
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